Effectiveness and Safety Outcomes of Standard of Care (SOC) Lisocabtagene Maraleucel (liso-cel) in Patients (Pts) with Relapsed or Refractory (R/R) Transformed Large B-Cell Lymphoma (tLBCL): Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) RegistryIris Isufi, Sairah Ahmed, Farah Toron et al.|Transplantation and Cellular Therapy|2025Cited by 1